We are live on
!
Find out more
ACP
Ashfield Capital Partners Portfolio holdings
AUM
$1.19B
1-Year Est. Return
14.56%
This Fund
S&P 500
This Quarter
Est. Return
+11.59%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$81.3M
(+8.8%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
238
New
6
Increased
36
Reduced
129
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$2.92M |
| 2 |
Intel
INTC
|
+$2.24M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$1.97M |
| 4 |
Visa
V
|
+$1.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$913K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$4.31M |
| 2 |
Cisco
CSCO
|
+$2.34M |
| 3 |
Netflix
NFLX
|
+$1.36M |
| 4 |
Rockwell Automation
ROK
|
+$1.1M |
| 5 |
BSCJ
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.75% |
| 2 | Healthcare | 16.49% |
| 3 | Industrials | 10.13% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Communication Services | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
226
DELISTED
Kellanova
K
| $212K | 0.02% |
+3,264
| New | +$198K |
|
227
Norfolk Southern
NSC
$75.1B
| $207K | 0.02% |
+1,065
| New | +$200K |
|
228
Campbell Soup
CPB
$6.64B
| $203K | 0.02% |
+4,116
| New | +$195K |
|
229
Alerian MLP ETF
AMLP
$12.9B
| $133K | 0.01% |
3,137
| – | – |
|
230
Destination XL Group
DXLG
$31.7M
| $131K | 0.01% |
102,221
| – | – |
|
231
Ambev
ABEV
$47.7B
| $111K | 0.01% |
23,765
| – | – |
|
|
BMY.RT
232
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $51K | 0.01% |
+16,931
| New | +$44K |
|
233
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| – | – |
-8,704
| Closed | -$766K |
|
234
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| – | – |
-7,126
| Closed | -$430K |
|
235
Xylem
XYL
$27.7B
| – | – |
-2,525
| Closed | -$201K |
|
|
BSCJ
236
DELISTED
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
| – | – |
-51,200
| Closed | -$1.08M |
|
|
VSM
237
DELISTED
Versum Materials, Inc.
VSM
| – | – |
-4,625
| Closed | -$245K |
|
|
CELG
238
DELISTED
Celgene Corp
CELG
| – | – |
-43,412
| Closed | -$4.31M |
|
Similar funds
MCM
DWM
H6H
SIM
AIL
CL
CCP
RIG
Ashfield Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Ashfield Capital Partners held 238 positions worth $1B, up 8.8% from $923M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ashfield Capital Partners's Q4 2019 filing shows 6 new, 36 increased, 129 reduced and 6 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,550 shares worth $214K. The largest sale was Celgene Corp, an estimated $4.31M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Ashfield Capital Partners's largest Q4 2019 buy was iShares Core S&P Small-Cap ETF: 2,550 shares worth $214K.
- Ashfield Capital Partners added most to IQVIA in Q4 2019, an estimated $2.92M increase.
- Ashfield Capital Partners's biggest Q4 2019 reduction was Cisco, cutting an estimated $2.34M.
- Ashfield Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $4.31M.
- Ashfield Capital Partners's ten largest holdings make up 30% of its $1B portfolio in Q4 2019.
- Ashfield Capital Partners opened 6 new positions and closed 6 in Q4 2019.
- Ashfield Capital Partners's portfolio value rose 8.8% quarter-over-quarter to $1B.
Based on Ashfield Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.